Literature DB >> 6242083

Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.

R W Darrell, S M Modak, C L Fox.   

Abstract

Norfloxacin is a new synthetic antibiotic with a broad spectrum of activity against gram-positive and gram-negative bacteria, and is more effective than the aminoglycosides against P aeruginosa. In this study norfloxacin was particularly effective in treatment of P aeruginosa infection of the rabbit cornea, and caused no toxicity in normal rabbit eyes after prolonged administration. The addition of silver to norfloxacin enhances its antipseudomonal activity, and broadens its spectrum to include antifungal activity. In this study, silver norfloxacin appears to be the most effective antibiotic against P aeruginosa corneal ulcer in the rabbit. Because of its broad antibacterial spectrum, silver norfloxacin may be useful in the initial treatment of bacterial corneal ulcer before the identity of the bacteria is known. Because of its low toxicity in topical administration, and its antifungal and antibacterial activity, silver norfloxacin may be helpful in prophylaxis against infection in chronic corneal ulcers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6242083      PMCID: PMC1298655     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  30 in total

1.  Antiviral activities of silver sulfadiazine in ocular infection.

Authors:  T Tokumaru; Y Shimizu; C L Fox
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-05

2.  Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.

Authors:  C L Fox
Journal:  Arch Surg       Date:  1968-02

3.  Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa.

Authors:  S M Modak; C L Fox
Journal:  Biochem Pharmacol       Date:  1973-10-01       Impact factor: 5.858

4.  Pseudomonas corneal ulcers in contact lens wearers. Epidemiology and treatment.

Authors:  B Golden; L H Fingerman; H F Allen
Journal:  Arch Ophthalmol       Date:  1971-05

5.  Pseudomonas ulceration of the cornea following major total body burn: a clinical study.

Authors:  W H Mitchell; B J Parson; L J Weiner
Journal:  J Trauma       Date:  1976-04

6.  Pathogenesis of corneal damage from pseudomonas exotoxin A.

Authors:  B H Iglewski; R P Burns; I K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-01       Impact factor: 4.799

7.  Pseudomonas-induced corneal ulcers associated with contaminated eye mascaras.

Authors:  L A Wilson; D G Ahearn
Journal:  Am J Ophthalmol       Date:  1977-07       Impact factor: 5.258

8.  In vitro antibacterial activity of AM-715, a new nalidixic acid analog.

Authors:  A Ito; K Hirai; M Inoue; H Koga; S Suzue; T Irikura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Amikacin treatment of Pseudomonas-caused corneal ulcer.

Authors:  K D Hansen; R F Meyer
Journal:  Arch Ophthalmol       Date:  1980-11
View more
  2 in total

1.  Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.

Authors:  J A Jacobson; N B Call; E M Kasworm; M S Dirks; R B Turner
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 2.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.